Digital pharmacy solutions can help brick and mortar locations become more efficient, according to Sarah Thomas, VP of sales and commercialization at HealthDyne and David Skomo, COO of HealthDyne.
Emphasizing best practices and a healthy culture rather than focusing narrowly on compensation will help medical groups thrive.
Managed care organizations must ensure that all of their members—including their youngest—receive the most equitable start in life. Here’s how to get started.
With the introduction of the Health Equity Index (HEI) to Star Ratings methodology, health plans have yet another incentive to address health disparities.
The growth of digital twin technology — paired with the transition towards personalized medicine — has left many healthcare industry professionals evaluating the potential of a “patient twin.”
The benefits space is changing and there is currently a shift to “enviable benefits” - ones that go beyond traditional health and retirement coverage. Many companies, especially those still doing well during the economic downturn, have ramped up benefits communication about existing support programs such as telemedicine, financial well-being and childcare.
An expert discusses the key unmet needs in current treatment approaches for idiopathic pulmonary fibrosis (IPF) and progressive pulmonary fibrosis (PPF).
Demand for mental health care is booming. With a shortage of psychiatrists, author of this opinion piece, Robert Krayn, asks how can we ensure providers are empowered to deliver the best care possible for their patients?
There are many misconceptions about healthcare technology, but you can improve your organization’s approach to IT by clearing them up and following these three steps.
Finerenone, a nonsteroidal mineralocorticoid receptor antagonist, has been studied extensively in patients with mildly reduced or preserved ejection fraction.
Data analytics allows providers to gain insights from performance management measures and metrics that hold the clues to financial viability under risk-based and pay-for-performance contracts. By embracing advanced analytics, hospitals and health systems can accelerate their path to value.
Artificial intelligence can help deal with everyday problems such as prior authorization and high utilization. But payers are also eyeing it for loftier purposes.
Telehealth solutions are here to stay.
Generic drugs account for 90% of the prescriptions filled in the United States. They are the backbone of healthcare providers’ treatment protocol and they are remarkably cost effective: despite being 90% of the prescriptions filled, generics account for only 20% of drug spending.
Diana Do, MD, and Steven Peskin, MD, MBA, FACP, discuss unmet needs and future approaches to treatment in wet AMD.
Medicare and Medicaid programs that serve the most-vulnerable Americans facing SDOH barriers can be major facilitators of appropriate non-emergency transportation to non-medical sites. But how do we determine what is appropriate, and what do we know about transportation services to non-medical sites today?
Lives can be saved, physician burnout and waste can be reduced, and drug costs can decrease by achieving medication optimization through comprehensive medication management.
Financial Toxicity is a growing concern for many cancer patients and caregivers, and with the continued rise in treatment costs, it can no longer be ignored.
In an early 2023 brief published by KFF, CMS transparency data for 2021 revealed an average denial rate of 17% for all in-network claims, with authorization denials reported as high as 24% of denial volume for some plans and medical necessity denial rates as high as 37% for others.
Diana Do, MD, and Steven Peskin, MD, MBA, FACP, discuss unmet needs and future approaches to treatment in wet AMD.
COVID-19 is not in the rearview mirror. Greater collaboration among organizations, and a new sense of purpose with regard to interoperability, is essential in this new era.
Even as many industries continue to suffer devastating setbacks due to the COVID-19 pandemic, one sector that has enjoyed an “embarrassment of profits” is health insurance.
Current strategies used to evaluate the performance of therapies used to treat atopic dermatitis and guide formulary decisions, and recommendations to help patients receive access to effective therapies.
Adherence measures developed by the Pharmacy Quality Alliance (PQA) are an important part of the Medicare Part D Star Ratings program. PQA has launched a Health Equity Technical Expert Panel to provide input on specific approaches to ensuring PQA’s measures support equitable health care.
Clinical data integration can mean navigating through an obstacle course of organizational and technical challenges. But it can show its ROI bona fides with digital chart review and other efforts.
Those with certain comorbidities, including peptic ulcer disease and renal failure, were at additional risk of developing C diff infection.